Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Charite University, Berlin, Germany
Sponsor:
Information provided by (Responsible Party):
Claudia Spies, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01388686
First received: July 5, 2011
Last updated: May 23, 2014
Last verified: May 2014

July 5, 2011
May 23, 2014
July 2011
October 2014   (final data collection date for primary outcome measure)
Total number of blood cultures drawn and total number of positive findings in ICUs [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Retrospective analysis of cases with positive bloodculture among patients in ICU setting compared to the total amount of blood cultures taken in the same period of time and same hospital.
Total number of blood cultures drawn and total number of positive findings in ICUs [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Retrospective analysis of cases with positive bloodculture among patients in ICU setting compared to the total amount of blood cultures taken in the syme period of time and same hospital.
Complete list of historical versions of study NCT01388686 on ClinicalTrials.gov Archive Site
Prevalence on CVC - associated sepsis/CLABSIs [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg
Retrospective Analysis of Proven Bacteremia, CVC-associated Infections and Sepsis

Structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg to collect data on the overall number of blood cultures (used) and the prevalence of (positive blood cultures in patients with) CVC - associated sepsis.

The use of CVC represents one of the major risk factors for sepsis, a highly prevalent disease in ICUs. Blood cultures obtained prior to antibiotic administration are part of the SSC Resuscitation Bundle and essential for the outcome of the patient. The CDC criteria to diagnose sepsis do not take into account the overall number of blood cultures obtained and thus, lead to an underestimation of the true incidence of sepsis. Up to now, few data is available on the total number of blood cultures obtained and the relation to the incidence of sepsis in German ICUs.

Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Patients with bacteremia on intensive care units of different primary and secondary care hospitals in the region of Berlin-Brandenburg.

Bacteremia
Not Provided
INABBRA
Participating hospitals in the INABBRA alliance.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
80
October 2014
October 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Intensive care units of hospitals in the INABBRA alliance.
  • Patients with bacteremia.

Exclusion Criteria:

  • Hospitals without intensive care unit.
Both
Not Provided
No
Contact: Claudia Spies, MD, Prof. +49 30 450 551001 claudia.spies@charite.de
Germany
 
NCT01388686
BAC_BLOOD
No
Claudia Spies, Charite University, Berlin, Germany
Charite University, Berlin, Germany
Not Provided
Study Director: Claudia Spies, MD, Prof. Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin
Charite University, Berlin, Germany
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP